Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3 AUD | 0.00% | +1.69% | -29.41% |
Evolution of the average Target Price on Paradigm Biopharmaceuticals Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- PAR Stock
- Consensus Paradigm Biopharmaceuticals Limited